Investigated
Are there human trials for lacosamide in osteoarthritis?
Short answer
Image: pmc.ncbi.nlm.nih.gov
Yes. A phase 2 randomized, placebo-controlled human trial tested 400 mg/day lacosamide for knee osteoarthritis, but it was terminated after a planned interim analysis and reported no safety concerns. The trial does not establish clinical benefit; newer positive findings are from human cells and animal models, not completed osteoarthritis treatment trials in people.
The views on this question
Two lenses on the same evidence. Source weight and the primary source ratio show what each rests on.
Alternative
Source weight 67%A broader translational reading sees lacosamide as a promising osteoarthritis research candidate rather than a clinically established treatment. Animal work and experiments using human cartilage cells support biological plausibility, but they do not replace evidence from completed human osteoarthritis trials; the earlier trial’s termination leaves efficacy unresolved.
- A 2014 rat osteoarthritis study reported antinociceptive effects of lacosamide, supporting a pain-mechanism hypothesis.
- A 2026 study found beneficial effects in human osteoarthritis chondrocytes, cartilage explants, and mice, including with intra-articular delivery.
- These laboratory and animal findings are not evidence that lacosamide has demonstrated efficacy in human osteoarthritis patients.
Follow the white rabbit
Deeper threads worth pulling on next.
- What was the terminated trial's design?Different angle, same storyLook into the phase 2 randomized placebo‑controlled knee OA trial’s enrollment, endpoints, interim analysis, and termination notes.
- Are there other lacosamide trials for pain?A different rabbit holeExplore clinical studies of lacosamide in neuropathic pain, low back pain, and other chronic pain conditions for efficacy signals.